Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

13.05.2024

1 Am J Epidemiol
2 Ann Intern Med
1 BMJ
1 Br J Ophthalmol
3 Diabet Med
4 Diabetes Care
15 Diabetes Obes Metab
1 Diabetologia
1 Invest Ophthalmol Vis Sci
4 J Clin Endocrinol Metab
2 J Diabetes Complications
1 Obstet Gynecol
16 PLoS One



    Am J Epidemiol

  1. HAMILTON F, Mitchell R, Ghazal P, Timpson N, et al
    Phenotypic Associations With the HMOX1 GT(n) Repeat in European Populations.
    Am J Epidemiol. 2024;193:718-726.
    >> Share


    Ann Intern Med

  2. O'BRIEN C, Dinneen SF
    In type 2 diabetes, the effectiveness and side effects of GLP-1 RAs vary.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0028.
    >> Share

  3. BATES ER
    In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
    >> Share


    BMJ

  4. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ. 2024;385:e077097.
    >> Share


    Br J Ophthalmol

  5. VINGOPOULOS F, Baldwin G, Katz R, Cui Y, et al
    Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy.
    Br J Ophthalmol. 2024 May 6:bjo-2023-323900. doi: 10.1136/bjo-2023-323900.
    >> Share


    Diabet Med

  6. HAUGVIK S, Hennekes M, Stice E, de Wit M, et al
    The diabetes body project: Study protocol of a multi-site trial of a virtually delivered eating disorder prevention program for young women with type 1 diabetes.
    Diabet Med. 2024 May 9:e15334. doi: 10.1111/dme.15334.
    >> Share

  7. SCHEUER SH, Fleetwood K, Wild SH, Jackson CA, et al
    Ethnic disparities in quality of diabetes care in Scotland: A national cohort study.
    Diabet Med. 2024 May 8:e15336. doi: 10.1111/dme.15336.
    >> Share

  8. NG SM, Evans ML, Oliver N, Rankin D, et al
    Bridging the digital divide: The UNBIASED national study to unravel the impact of ethnicity and deprivation on diabetes technology disparities in the United Kingdom.
    Diabet Med. 2024 May 8:e15346. doi: 10.1111/dme.15346.
    >> Share


    Diabetes Care

  9. JOHANSSON KS, Jimenez-Solem E, Petersen TS, Christensen MB, et al
    Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020.
    Diabetes Care. 2024 May 6:dc240011. doi: 10.2337/dc24-0011.
    >> Share

  10. PANE A, Videla L, Calvet A, Viaplana J, et al
    Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes.
    Diabetes Care. 2024 May 7:dc232213. doi: 10.2337/dc23-2213.
    >> Share

  11. BILAL A, Yi F, Whitaker K, Igudesman D, et al
    Impaired Awareness of Hypoglycemia in Older Adults With Type 1 Diabetes: A Post Hoc Analysis of the WISDM Study.
    Diabetes Care. 2024 May 7:dc240201. doi: 10.2337/dc24-0201.
    >> Share

  12. BUCKELL J, Mitchell CA, Fryer K, Newbert C, et al
    Erratum. Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K.. Diabetes Care 2024;47:739-746.
    Diabetes Care. 2024 May 10:dc24er07b. doi: 10.2337.
    >> Share


    Diabetes Obes Metab

  13. THOMAS L, Martel E, Rist W, Uphues I, et al
    The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.
    Diabetes Obes Metab. 2024;26:2368-2378.
    >> Share

  14. MILANOVIC S, Dedic N, Lew R, Burton D, et al
    TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes.
    Diabetes Obes Metab. 2024;26:2466-2475.
    >> Share

  15. LIU Y, Kimita W, Shamaitijiang X, Skudder-Hill L, et al
    Intra-pancreatic fat is associated with continuous glucose monitoring metrics.
    Diabetes Obes Metab. 2024;26:2359-2367.
    >> Share

  16. STRATMANN B, Eggers B, Mattern Y, de Carvalho TS, et al
    Maladaptive response following glucose overload in GLUT4-overexpressing H9C2 cardiomyoblasts.
    Diabetes Obes Metab. 2024;26:2379-2389.
    >> Share

  17. LUIZ MM, Maximo RO, de Oliveira DC, Ramirez PC, et al
    Could poor glycaemic control be a predictor of walking speed decline in older adults? Evidence from the English Longitudinal Study of Ageing.
    Diabetes Obes Metab. 2024;26:2349-2358.
    >> Share

  18. PULKKINEN MA, Varimo TJ, Hakonen ET, Hero MT, et al
    During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.
    Diabetes Obes Metab. 2024;26:2431-2438.
    >> Share

  19. ABDELMALEK MF, Harrison SA, Sanyal AJ
    The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis.
    Diabetes Obes Metab. 2024;26:2001-2016.
    >> Share

  20. HASHEMY H, Nguyen A, Khafagy R, Roshandel D, et al
    Analyses of potential causal contributors to increased waist/hip ratio-associated cardiometabolic disease: A combined and sex-stratified Mendelian randomization study.
    Diabetes Obes Metab. 2024;26:2284-2291.
    >> Share

  21. TOSHIMITSU T, Gotou A, Sashihara T, Hojo K, et al
    Ingesting probiotic yogurt containing Lactiplantibacillus plantarum OLL2712 improves glycaemic control in adults with prediabetes in a randomized, double-blind, placebo-controlled trial.
    Diabetes Obes Metab. 2024;26:2239-2247.
    >> Share

  22. SILVERII GA, Marinelli C, Mannucci E, Rotella F, et al
    Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials.
    Diabetes Obes Metab. 2024;26:2505-2508.
    >> Share

  23. PETERMANN-ROCHA F, Apolinar E, Nazar G, Diaz-Toro F, et al
    Associations of diabesity with all-cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study.
    Diabetes Obes Metab. 2024;26:2199-2208.
    >> Share

  24. SHIKAMURA M, Takayama A, Takeuchi M, Kawakami K, et al
    Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A
    Diabetes Obes Metab. 2024 May 6. doi: 10.1111/dom.15632.
    >> Share

  25. MORIOKA T, Takeuchi M, Ozeki A, Emoto M, et al
    A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).
    Diabetes Obes Metab. 2024 May 7. doi: 10.1111/dom.15644.
    >> Share

  26. KANAOKA T, Wakui H, Yano Y, Nagasu H, et al
    Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
    Diabetes Obes Metab. 2024 May 8. doi: 10.1111/dom.15611.
    >> Share

  27. ALMUALLEM S, Ali AK, Vourtzoumis P, Demyttenaere S, et al
    Validation of the Individualized Metabolic Surgery score in predicting long-term remission of diabetes after duodenal switch-type procedures.
    Diabetes Obes Metab. 2024 May 9. doi: 10.1111/dom.15647.
    >> Share


    Diabetologia

  28. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    >> Share


    Invest Ophthalmol Vis Sci


  29. Erratum in: Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
    Invest Ophthalmol Vis Sci. 2024;65:12.
    >> Share


    J Clin Endocrinol Metab

  30. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
    Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
    >> Share

  31. DENG R, Chen W, Zhang Z, Zhang J, et al
    Association between visceral obesity index and diabetes: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2024 May 6:dgae303. doi: 10.1210.
    >> Share

  32. NICOLI CD, Long DL, Plante TB, Judd SE, et al
    N-Terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
    J Clin Endocrinol Metab. 2024 May 4:dgae301. doi: 10.1210.
    >> Share

  33. OKOSHI C, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of gestational diabetes in women with PCOS based on body mass index: The Japan Environment and Children's Study.
    J Clin Endocrinol Metab. 2024 May 4:dgae293. doi: 10.1210.
    >> Share


    J Diabetes Complications

  34. HUANG JX, Copeland TP, Pitts CE, Myers SR, et al
    Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes.
    J Diabetes Complications. 2024;38:108762.
    >> Share

  35. SHAPIRO ALB, Tjaden AH, Edelstein SL, Kahn SE, et al
    The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study.
    J Diabetes Complications. 2024;38:108764.
    >> Share


    Obstet Gynecol

  36. CRUMP C, Sundquist J, Sundquist K
    Long-Term Risk of Type 2 Diabetes After Preterm Delivery or Hypertensive Disorders of Pregnancy.
    Obstet Gynecol. 2024 May 9. doi: 10.1097/AOG.0000000000005604.
    >> Share


    PLoS One

  37. CHEN W, Sun X, Han J, Wu X, et al
    Joint effect of abnormal systemic immune-inflammation index (SII) levels and diabetes on cognitive function and survival rate: A population-based study from the NHANES 2011-2014.
    PLoS One. 2024;19:e0301300.
    >> Share

  38. DERESE A, Gebreegzhiabhere Y, Medhin G, Sirgu S, et al
    Impact of depression on self-efficacy, illness perceptions and self-management among people with type 2 diabetes: A systematic review of longitudinal studies.
    PLoS One. 2024;19:e0302635.
    >> Share

  39. WILSON D, Diji AK, Marfo R, Amoh P, et al
    Dietary adherence among persons with type 2 diabetes: A concurrent mixed methods study.
    PLoS One. 2024;19:e0302914.
    >> Share

  40. ALSHAMMARI F, Ansari M, Khan KU, Neupane D, et al
    Health-related quality of life among people with diabetes: A cross-sectional study in Hail region, Saudi Arabia ?.
    PLoS One. 2024;19:e0299995.
    >> Share

  41. ATRESE T, Fekadu L, Kune G, Shita A, et al
    Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study.
    PLoS One. 2024;19:e0302167.
    >> Share

  42. IDRIS NF, Ismail MA, Jaya MIM, Ibrahim AO, et al
    Stacking with Recursive Feature Elimination-Isolation Forest for classification of diabetes mellitus.
    PLoS One. 2024;19:e0302595.
    >> Share

  43. OTA A, Kitamura H, Sugimoto K, Ogawa M, et al
    Comparative studies of hair shaft components between healthy and diseased donors.
    PLoS One. 2024;19:e0301092.
    >> Share


  44. Correction: Can diabetes patients seeking a second hospital get better care? Results from nested case-control study.
    PLoS One. 2024;19:e0303550.
    >> Share

  45. SELVAVINAYAGAM TS, Viswanathan V, Ramalingam A, Kangusamy B, et al
    Prevalence of Noncommunicable Disease (NCDs) risk factors in Tamil Nadu: Tamil Nadu STEPS Survey (TN STEPS), 2020.
    PLoS One. 2024;19:e0298340.
    >> Share

  46. SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
    Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
    PLoS One. 2024;19:e0302219.
    >> Share

  47. SUGLO JN, Winkley K, Sturt J
    Improving foot self-care in people with diabetes in Ghana: A development and feasibility randomised trial of a context appropriate, family-orientated diabetic footcare intervention.
    PLoS One. 2024;19:e0302385.
    >> Share

  48. CHONA EZ, Kayange LF, Iseselo MK
    Barriers and facilitators to satisfaction with diabetes care: The perspectives of patients attending public diabetic clinics in Dar es Salaam, Tanzania.
    PLoS One. 2024;19:e0302858.
    >> Share

  49. YINGKLANG M, Chaidee A, Dangtakot R, Jantawong C, et al
    Correction: Association of Strongyloides stercoralis infection and type 2 diabetes mellitus in northeastern Thailand: Impact on diabetic complication-related renal biochemical parameters.
    PLoS One. 2024;19:e0303774.
    >> Share

  50. ABDEL-RAHMAN N, Manor O, Cohen A, Elran E, et al
    Adherence to diabetes quality indicators in primary care and all-cause mortality: A nationwide population-based historical cohort study.
    PLoS One. 2024;19:e0302422.
    >> Share

  51. STOWELL M, Dobson R, Garner K, Baig M, et al
    Digital interventions for self-management of prediabetes: A scoping review.
    PLoS One. 2024;19:e0303074.
    >> Share

  52. SHUMYE AF, Tegegne MM, Eticha BL, Bekele MM, et al
    Prevalence and associated factors of proliferative diabetic retinopathy among adult diabetic patients in Northwest Ethiopia, 2023: A cross-sectional multicenter study.
    PLoS One. 2024;19:e0303267.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016